claim
The combination of Dasatinib and quercetin can eliminate senescent mesenchymal embryonic fibroblasts from Ercc1−/− mice and bone marrow mesenchymal progenitors from old mice, whereas either drug alone is ineffective.

Authors

Sources

Referenced by nodes (1)